Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-06-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine from Carlsbad Technology, Inc.
-
FDA label_change · 2012-05-18FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Pantoprazole Sodium (Lannett Company) under ANDA 078281, signaling changes to the labeling f…
-
FDA approval · 2012-05-18FDA Approved: BASIC CARE LANSOPRAZOLE — Original Application (Amazon.com Services LLC)
FDA approved a generic lansoprazole product, BASIC CARE LANSOPRAZOLE, under an original application by Amazon.com Services LLC. This provide…
-
FDA approval · 2012-05-18FDA Approved: LANSOPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for lansoprazole from Dr. Reddy's Laboratories, authorizing a generic lansoprazole product.
-
FDA approval · 2012-05-11FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-10FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX I.V. (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-05-08FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for ACIPHEX (rabeprazole sodium).
-
FDA approval · 2012-04-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for an omeprazole and sodium bicarbonate product, updating its labeling…
-
FDA approval · 2012-04-18FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for lansoprazole, authorizing the marketing of a generic lansoprazole…
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
FDA approval · 2012-03-23FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approves Apotex Corp's supplemental application for omeprazole (generic) under ANDA076048. This authorizes the marketing of a generic om…
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
-
FDA approval · 2012-02-13FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole submitted by Sandoz Inc under ANDA075757 (generic omeprazole).
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) [Phase 3]
Phase 3 trial comparing esomeprazole 20 mg or 40 mg with placebo to prevent peptic ulcers in subjects taking low-dose aspirin; results poste…
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, updating the labeling under a supplemental…
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Pantoprazole Sodium by Torrent Pharmaceuticals Limited. The approval denotes changes under a sup…
-
FDA approval · 2012-01-11FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for pantoprazole submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients [Phase 4]
This Phase 4 trial assesses the safety and efficacy of Albis in preventing aspirin-induced gastrointestinal ulcers in patients taking low-do…
-
FDA approval · 2011-12-15FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2011-12-07FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Oceanside Pharmaceuticals' omeprazole and sodium bicarbonate, updating labeling through a supple…
-
FDA approval · 2011-10-31FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).